236 related articles for article (PubMed ID: 31749595)
1. Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor.
Xu SS; Xu HX; Wang WQ; Li S; Li H; Li TJ; Zhang WH; Liu L; Yu XJ
World J Gastroenterol; 2019 Nov; 25(41):6248-6257. PubMed ID: 31749595
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.
Zhou B; Zhan C; Wu J; Liu J; Zhou J; Zheng S
Med Sci Monit; 2017 Nov; 23():5574-5588. PubMed ID: 29168979
[TBL] [Abstract][Full Text] [Related]
3. Standard pre- and postoperative determination of chromogranin a in resectable non-functioning pancreatic neuroendocrine tumors--diagnostic accuracy: NF-pNET and low tumor burden.
Jilesen AP; Busch OR; van Gulik TM; Gouma DJ; Nieveen van Dijkum EJ
Dig Surg; 2014; 31(6):407-14. PubMed ID: 25572908
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.
Zhang SR; Yao L; Wang WQ; Xu JZ; Xu HX; Jin W; Gao HL; Wu CT; Qi ZH; Li H; Li S; Ni QX; Yu XJ; Fu DL; Liu L
Ann Surg Oncol; 2018 Dec; 25(13):3984-3993. PubMed ID: 30171511
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors.
Fisher AV; Lopez-Aguiar AG; Rendell VR; Pokrzywa C; Rocha FG; Kanji ZS; Poultsides GA; Makris EA; Dillhoff ME; Beal EW; Fields RC; Panni RZ; Idrees K; Smith PM; Cho CS; Beems MV; Maithel SK; Winslow ER; Abbott DE; Weber SM
J Gastrointest Surg; 2019 Apr; 23(4):651-658. PubMed ID: 30659439
[TBL] [Abstract][Full Text] [Related]
6. A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Oncotarget; 2016 Jul; 7(27):42045-42058. PubMed ID: 27275541
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of preoperative gamma-glutamyltransferase to lymphocyte ratio index in nonfunctional pancreatic neuroendocrine tumors after curative resection.
Zhou B; Zhan C; Wu J; Liu J; Zhou J; Zheng S
Sci Rep; 2017 Oct; 7(1):13372. PubMed ID: 29042631
[TBL] [Abstract][Full Text] [Related]
8. Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis.
Gaitanidis A; Patel D; Nilubol N; Tirosh A; Sadowski S; Kebebew E
Ann Surg Oncol; 2018 Jan; 25(1):122-130. PubMed ID: 29134377
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages.
Harimoto N; Hoshino K; Muranushi R; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Suzuki H; Arakawa K; Hirai K; Fukazawa T; Ikota H; Shirabe K
Pancreatology; 2019 Sep; 19(6):897-902. PubMed ID: 31409525
[TBL] [Abstract][Full Text] [Related]
10. Microscopic venous invasion in patients with pancreatic neuroendocrine tumor as a potential predictor of postoperative recurrence.
Nanno Y; Toyama H; Otani K; Asari S; Goto T; Terai S; Ajiki T; Zen Y; Fukumoto T; Ku Y
Pancreatology; 2016; 16(5):882-7. PubMed ID: 27350059
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
Karaman K; Bostanci EB; Aksoy E; Kurt M; Celep B; Ulas M; Dalgic T; Surmelioglu A; Hayran M; Akoglu M
Eur J Intern Med; 2011 Dec; 22(6):e95-8. PubMed ID: 22075321
[TBL] [Abstract][Full Text] [Related]
12. Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG).
Panni RZ; Lopez-Aguiar AG; Liu J; Poultsides GA; Rocha FG; Hawkins WG; Strasberg SM; Trikalinos NA; Maithel S; Fields RC;
J Surg Oncol; 2019 Sep; 120(4):632-638. PubMed ID: 31339198
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours.
Song KB; Kim SC; Kim JH; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ
ANZ J Surg; 2016 Jul; 86(7-8):563-7. PubMed ID: 25040037
[TBL] [Abstract][Full Text] [Related]
14. Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer.
Xu SS; Li S; Xu HX; Li H; Wu CT; Wang WQ; Gao HL; Jiang W; Zhang WH; Li TJ; Ni QX; Liu L; Yu XJ
World J Gastroenterol; 2020 Feb; 26(8):828-838. PubMed ID: 32148380
[TBL] [Abstract][Full Text] [Related]
15. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
[TBL] [Abstract][Full Text] [Related]
16. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
World J Gastroenterol; 2017 Dec; 23(47):8376-8386. PubMed ID: 29307997
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.
Vashist YK; Uzunoglu G; Deutsch L; Kalinin V; Zehler O; Alzadjali A; Kutup A; Izbicki JR; Yekebas EF
J Surg Res; 2011 Apr; 166(2):e121-7. PubMed ID: 21236443
[TBL] [Abstract][Full Text] [Related]
18. Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms.
Kaltenborn A; Matzke S; Kleine M; Krech T; Ramackers W; Vondran FW; Klempnauer J; Bektas H; Schrem H
J Surg Oncol; 2016 Feb; 113(2):194-202. PubMed ID: 26709239
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
[TBL] [Abstract][Full Text] [Related]
20. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer.
Chawla A; Huang TL; Ibrahim AM; Hardacre JM; Siegel C; Ammori JB
HPB (Oxford); 2018 May; 20(5):398-404. PubMed ID: 29221789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
